Virtu Financial LLC Lyra Therapeutics, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.26 - $6.25 $5,138 - $123,512	19,762 Added 165.68%	31,690 $9,000
Q1 2024 May 20, 2024	BUY	$4.55 - $6.53 $54,272 - $77,889	11,928 New	11,928 $74,000
Q3 2023 Nov 14, 2023	BUY	$2.95 - $4.8 $57,873 - $94,166	19,618 New	19,618 $77,000
Q1 2022 May 17, 2022	SELL	$3.5 - $5.36 $45,944 - $70,360	-13,127 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$4.22 - $9.41 $55,395 - $123,525	13,127 New	13,127 $57,000

32M

21.1K

400

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $6.05M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.